Form 4: Supernus Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Jonathan Rubin, SVP, Chief Medical Officer of Supernus Pharmaceuticals, Inc., received 750 shares of common stock on July 29, 2026.
Summary
- Grant/award: acquired 750 Performance Share Unit on July 29, 2026; holds 750 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jonathan Rubin — Officer (SVP, Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Grant/award | Performance Share Unit | 750 | — | — | 750 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Grant/award (750 shares) |
Keywords
insider transaction, Form 4, SUPN, SUPERNUS PHARMACEUTICALS, INC., neutral, Jonathan Rubin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.